Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetes
Makiko Nakamura,1 Nobuo Sasai,2 Ichiro Hisatome,3 Kimiyoshi Ichida11Department of Pathophysiology, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan; 2Sasai Clinic, Kanagawa, Japan; 3Division of Regenerative Medicine and Therapeutics, Institute of Regenerative Medicine and Biofunction, G...
Guardado en:
Autores principales: | Nakamura M, Sasai N, Hisatome I, Ichida K |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5c55511bf0884c1e9c5dce75ba44ac81 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Association between the Serum Uric Acid Level and Hypertension in Middle-Aged and Elderly Adults
por: Xianpeng Xu, et al.
Publicado: (2021) -
Pharmacokinetic study on the interaction between succinic acid and irbesartan in rats and its potential mechanism
por: Yongpeng Wang, et al.
Publicado: (2021) -
Effect of statin therapy on vaspin levels in type 2 diabetic patients
por: Al-Azzam SI, et al.
Publicado: (2013) -
Elevated Serum Uric Acid is Associated With Poor Survival in Advanced HCC Patients and Febuxostat Improves Prognosis in HCC Rats
por: Le Wu, et al.
Publicado: (2021) -
Neuropeptide Y: a potential theranostic biomarker for diabetic peripheral neuropathy in patients with type-2 diabetes
por: Noo Ree Cho, et al.
Publicado: (2021)